Sequence information
Variant position: 850 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1980 The length of the canonical sequence.
Location on the sequence:
MELSLADVEGLSVLRSFRLL
R VFKLAKSWPTLNMLIKIIGN
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MELSLADVEGLSVLRSFRLLR VFKLAKSWPTLNMLIKIIGN
Mouse MELGLADVEGLSVLRSFRLLR VFKLAKSWPTLNMLIKIIGN
Rat MELSLADVEGLSVLRSFRLLR VFKLAKSWPTLNMLIKIIGN
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1980
Sodium channel protein type 8 subunit alpha
Transmembrane
840 – 857
Helical; Name=S4 of repeat II
Repeat
735 – 1007
II
Literature citations
SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability.
Kong W.; Zhang Y.; Gao Y.; Liu X.; Gao K.; Xie H.; Wang J.; Wu Y.; Zhang Y.; Wu X.; Jiang Y.;
Epilepsia 56:431-438(2015)
Cited for: VARIANTS DEE13 PHE-407; GLN-850; THR-890; CYS-1596 AND GLN-1617;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.